πŸ‡ΊπŸ‡Έ FDA
Patent

US 6608087

Gyrase inhibitors and uses thereof

expired A61KA61K31/4155A61K31/421

Quick answer

US patent 6608087 (Gyrase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Aug 19 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/4155, A61K31/421, A61K31/422, A61K31/427